DaVita (NYSE:DVA) Price Target Increased to $100.00 by Analysts at UBS Group

Posted by Defense World Staff on May 10th, 2023

DaVita (NYSE:DVA – Get Rating) had its target price hoisted by UBS Group from $91.00 to $100.00 in a research report report published on Tuesday, The Fly reports.

A number of other equities analysts also recently commented on the stock. Cowen boosted their target price on shares of DaVita from $76.00 to $90.00 and gave the stock an outperform rating in a report on Thursday, February 23rd. StockNews.com assumed coverage on shares of DaVita in a report on Thursday, March 16th. They issued a buy rating for the company. Bank of America boosted their target price on shares of DaVita from $86.00 to $96.00 in a report on Tuesday. Truist Financial boosted their target price on shares of DaVita from $84.00 to $90.00 and gave the stock a hold rating in a report on Thursday, February 23rd. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of DaVita from $72.00 to $85.00 in a report on Thursday, February 23rd. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of Hold and a consensus target price of $96.43.

DaVita Trading Up 12.9 %

DVA stock opened at $100.72 on Tuesday. The firm has a fifty day moving average price of $82.33 and a 200 day moving average price of $79.10. DaVita has a fifty-two week low of $65.28 and a fifty-two week high of $106.71. The company has a debt-to-equity ratio of 9.92, a quick ratio of 1.16 and a current ratio of 1.20. The firm has a market cap of $9.13 billion, a PE ratio of 17.43, a price-to-earnings-growth ratio of 1.79 and a beta of 0.93.

DaVita (NYSE:DVA – Get Rating) last released its quarterly earnings data on Monday, May 8th. The company reported $1.58 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.50. The firm had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.84 billion. DaVita had a return on equity of 77.49% and a net margin of 4.40%. The firm’s quarterly revenue was up 2.0% on a year-over-year basis. During the same period in the previous year, the company posted $1.61 earnings per share. Sell-side analysts anticipate that DaVita will post 5.93 earnings per share for the current fiscal year.

Insider Activity at DaVita

In related news, Director Charles Berg sold 735 shares of the company’s stock in a transaction that occurred on Wednesday, March 1st. The stock was sold at an average price of $81.78, for a total value of $60,108.30. Following the sale, the director now owns 17,164 shares in the company, valued at $1,403,671.92. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.00% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of DVA. Raymond James & Associates lifted its holdings in DaVita by 4.0% in the first quarter. Raymond James & Associates now owns 22,651 shares of the company’s stock valued at $2,562,000 after acquiring an additional 865 shares during the period. American Century Companies Inc. lifted its holdings in DaVita by 37.4% in the first quarter. American Century Companies Inc. now owns 6,555 shares of the company’s stock valued at $741,000 after acquiring an additional 1,785 shares during the period. US Bancorp DE lifted its holdings in DaVita by 63.6% in the first quarter. US Bancorp DE now owns 2,998 shares of the company’s stock valued at $338,000 after acquiring an additional 1,166 shares during the period. Cambridge Investment Research Advisors Inc. lifted its holdings in DaVita by 7.3% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 3,551 shares of the company’s stock valued at $402,000 after acquiring an additional 242 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund raised its stake in shares of DaVita by 847.8% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,090 shares of the company’s stock worth $123,000 after buying an additional 975 shares during the period. 86.52% of the stock is owned by institutional investors and hedge funds.

About DaVita

(Get Rating)

DaVita, Inc engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure.

Analyst Recommendations for DaVita (NYSE:DVA)

Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.